Uploaded September 2023 | Updated September 2026, 27 minutes ago
Hear Arthur Dondi, a PhD candidate from ETH Zürich discuss how he envisions Revio's higher throughput and accuracy will advance his research in ovarian cancer therapy.
Learn more about PacBio at pacb.com
Legal & Trademarks: Visit pacb.com/legal-and-trademarks
Hear Arthur Dondi, a PhD candidate from ETH Zürich discuss how he envisions Revio's higher throughput and accuracy will advance his research in ovarian cancer therapy.
Learn more about PacBio at pacb.com
Legal & Trademarks: Visit pacb.com/legal-and-trademarks










